OBJECTIVES Following the introduction of jurisdictional maternal pertussis vaccination
programs in Australia, we estimated maternal vaccine effectiveness (VE) and whether …

Background. Infants with pertussis infection are at risk of severe clinical illness and death.
Several countries, including the United Kingdom, have introduced maternal pertussis …

METHODS This inception cohort study comprised women whose pregnancies ended
between September 1, 2015, and December 31, 2017, in Victoria, Australia. Maternal …

Summary Background In October, 2012, a pertussis vaccination programme for pregnant
women was introduced in response to an outbreak across England. We aimed to assess the …

Background Maternal pertussis immunisation was introduced during the pertussis
resurgence in England in 2012 as a temporary measure to protect infants too young to be …

Background Infants are at the highest risk of severe complications–including death–as a
result of pertussis infection. Controlling pertussis in this group has been challenging …

Background England's third-trimester maternal pertussis vaccination, introduced in October
2012, was extended to the second trimester in 2016. Maternal vaccination provides high …

Infants are vulnerable to pertussis infection particularly before initiation of pertussis
vaccination. Maternal pertussis vaccination during pregnancy has been introduced in a …

Background Pertussis vaccination during pregnancy can prevent 91% of infant infections. In
2015, antenatal pertussis vaccination programs were introduced across Australia. Methods …

Background PERTINENT is an active hospital-based surveillance system for pertussis in
infants. In 2019, four of the six participating European countries recommended pertussis …